The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

NCT04433845 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Treatment Resistant Depression

Interventions

DRUG: Psilocybin

Sponsor

Sheppard Pratt Health System

Collaborators

[object Object]